Early Adherence to Antiretroviral Medication as a Predictor of Long-Term HIV Virological Suppression: Five-Year Follow Up of an Observational Cohort

Nathan Ford, Marta Darder, Tim Spelman et al. · 2010

Read Early Adherence to Antiretroviral Medication as a Predictor of Long-Term HIV Virological Suppression: Five-Year Follow Up of an Observational Cohort by Nathan Ford, Marta Darder, Tim Spelman et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010460.txt.

Description

Nathan Ford and colleagues asked whether early pill-taking habits predict long-term HIV control, in PLOS ONE in 2010. Skipping antiretroviral doses lets the virus rebound and gain resistance. Earlier studies linked adherence and virus suppression at single time points. This team followed a patient group for five years. They tested whether adherence measured at the start foretold later failure.

Early habits did carry lasting information about risk. That makes early support for new patients especially valuable. Clinics could flag strugglers sooner and help before failure sets in. Five-year follow-up is rare and gives the claim weight. The study turns a simple measure, early adherence, into a planning tool for lifelong treatment.

Catalog record

CREATORNathan Ford, Marta Darder, Tim Spelman et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE19 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010460

Browse the full library · About the Tower of Babel